early recurrence

You have access
Clinical Significance of Early Recurrence After Curative Resection of Colorectal Cancer
NATSUKO YAMAUCHI, TAKERU MATSUDA, RYUICHIRO SAWAD, HIROSHI HASEGAWA, KIMIHIRO YAMASHITA, HITOSHI HARADA, NAOKI URAKAWA, HIRONOBU GOTO, SHINGO KANAJI, TARO OSHIKIRI and YOSHIHIRO KAKEJI

Anticancer Research November 2022, 42 (11) 5553-5559; DOI: https://doi.org/10.21873/anticanres.16061
You have access
Prognostic Factors of Potential Early Recurrence of Hypopharyngeal Carcinoma
DAISUKE BABA, CHIHIRO FUSHIMI, KENJI HANYU, TATSUO MASUBUCHI, YUICHIRO TADA and KOKI MURA

Anticancer Research November 2021, 41 (11) 5761-5766; DOI: https://doi.org/10.21873/anticanres.15392
You have access
Efficacy and Feasibility of Adjuvant Gemcitabine Plus Cisplatin Chemotherapy After Major Hepatectomy for Biliary Tract Cancer
SHOZO MORI, TAKU AOKI, TAKAYUKI SHIRAKI, TAKAYUKI SHIMIZU, TAKAMUNE YAMAGUCHI, KYUNG-HWA PARK, TAKATSUGU MATSUMOTO, YUHKI SAKURAOKA, YUKIHIRO ISO and KEIICHI KUBOTA

Anticancer Research October 2021, 41 (10) 5231-5240; DOI: https://doi.org/10.21873/anticanres.15342
You have access
Tumor Size and N2 Lymph Node Metastasis Are Significant Risk Factors for Early Recurrence in Completely Resected Centrally Located Primary Lung Cancer Patients
TAKUMA TSUKIOKA, NOBUHIRO IZUMI, HIROAKI KOMATSU, HIDETOSHI INOUE, HIKARU MIYAMOTO, RYUICHI ITO, TAKUYA KIMURA and NORITOSHI NISHIYAMA

Anticancer Research April 2021, 41 (4) 2165-2169; DOI: https://doi.org/10.21873/anticanres.14989
You have access
HER2 Gene Amplification in ER-positive HER2 Immunohistochemistry 0 or 1+ Breast Cancer With Early Recurrence
HIROKO YAMASHITA, NAOKO ISHIDA, YUTAKA HATANAKA, KANAKO HAGIO, TOMOHIRO OSHINO, TAKASHI TAKESHITA, HIROMI KANNO-OKADA, AI SHIMIZU, KANAKO C. HATANAKA and YOSHIHIRO MATSUNO

Anticancer Research February 2020, 40 (2) 645-652; DOI: https://doi.org/10.21873/anticanres.13994
You have access
Prognostic Factors for Post-recurrent Survival in Hepatocellular Carcinoma After Curative Resection
RYO SAITO, HIDETAKE AMEMIYA, NAOHIRO HOSOMURA, HIROMICHI KAWAIDA, SUGURU MARUYAMA, HIROKI SHIMIZU, SHINJI FURUYA, HIDENORI AKAIKE, YOSHIHIKO KAWAGUCHI, MAKOTO SUDO, SHINGO INOUE, HIROSHI KONO and DAISUKE ICHIKAWA

Anticancer Research June 2019, 39 (6) 3033-3038; DOI: https://doi.org/10.21873/anticanres.13436
You have access
Combining the Glasgow Prognostic Score and Serum Carbohydrate Antigen 19-9 Level Improves the Ability to Predict Early Recurrence in Resected Pancreatic Cancer Patients Receiving Adjuvant Gemcitabine
KOJI NUMATA, SOICHIRO MORINAGA, YUSUKE KATAYAMA, SHO SAWAZAKI, MASAKATSU NUMATA, TENI GODAI, AKIO HIGUCHI, MANABU SHIOZAWA, YASUSHI RINO, MUNETAKA MASUDA and MAKOTO AKAIKE

Anticancer Research May 2016, 36 (5) 2467-2474;

Main menu

User menu

Search

early recurrence